Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66]

S Novello¹, V Torri², C Grohe³, S Kurz⁴, M Serke⁵, T Wehler⁵, A Meyer⁶, D Ladage⁶, M Geissler⁷, I Colantonio⁸, C Cauchi⁸, E Stoelben⁹, A Ceribelli¹⁰, C Kropf-Sanchen¹¹, G Valmadre¹², G Borra¹³, M Schena¹⁴, A Morabito¹⁵, A Santo¹⁶, V Gregorc¹⁷, R Chiari¹⁸, M Reck¹⁹, G Schmid-Bindert²⁰, G Folprecht²¹, F Griesinger²², A Follador²³, P Pedrazzoli²⁴, A Bearz²⁵, O Caffo²⁶, N J Dickgreber²⁷, L Irtelli²⁸, G Wiest²⁹, V Monica³⁰, L Porcu², C Manegold³¹, G V Scagliotti³⁰

Affiliations

¹ University of Torino, Department of Oncology at San Luigi Hospital, Orbassano (Torino), Italy. Electronic address: silvia.novello@unito.it.
² Laboratory of Methodology for Clinical Research, Oncology Department at Instituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
³ Department of Respiratory Diseases, Evangelische Lungenklinik Berlin, Berlin, Germany.
⁴ Evangelische Lungenklinik Berlin, Berlin, Germany.
⁵ Thorax Center Clinic for Haematology, Oncology, Pulmonology and Palliative Medicine, Evangelisches Krankenhaus Hamm, Hamm, Germany.
⁶ Department of Pneumology, Maria Hilf Hospital, Moenchengladbach, Germany.
⁷ Esslingen Cancer Center Department of Oncology, Gastroenterology and Infectious Diseases Klinikum Esslingen, Esslingen, Germany.
⁸ Division of Oncology, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy.
⁹ Lung Clinic, Cologne-Merheim Hospital, Cologne, Germany.
¹⁰ Division of Clinical Oncology A, Istituto Nazionale Regina Elena per lo Studio e la Cura dei Tumori, Rome, Italy.
¹¹ Department of Pulmonology, Internal Medicine II, University of Ulm, Ulm, Germany.
¹² Division of Clinical Oncology, Ospedale di Sondalo, Sondrio, Italy.
¹³ Division of Clinical Oncology, AOU Maggiore della Carità, Novara, Italy.
¹⁴ Division of Clinical Oncology I, AOU Città della Salute e della Scienza, Turin, Italy.
¹⁵ Division of Clinical Oncology and Thoracic Pneumology, IRCCS Fondazione Pascale, Naples, Italy.
¹⁶ Complex Operative Unit of Oncology - Gruppo Interdisciplinare Veronese Oncologia Polmonare (GIVOP), Verona, Italy.
¹⁷ Division of Clinical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
¹⁸ Division of Clinical Oncology, Azienda Ospedaliera di Perugia, Ospedale Santa Maria della Misericordia, Perugia, Italy.
¹⁹ Oncology Department, LungenClinic Grosshansdorf, Grosshansdorf, Germany.
²⁰ Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
²¹ University Hospital Carl Gustav Carus Medical Department I Dresden, Dresden, Germany.
²² Clinic for Haematology and Oncoloy, Medizinischer Campus Universität Oldenburg, Oldenburg, Germany.
²³ Department of Oncology, Presidio Ospedaliero Universitario Santa Maria della Misericordia, Azienda Sanitaria Universitaria Integrata Friuli Centrale, Udine, Italy.
²⁴ Medical Oncology, Fondazione IRCCS Policlinico S. Matteo and Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy.
²⁵ Division of Clinical Oncology, Centro di Riferimento Oncologico, Aviano, Italy.
²⁶ Division of Clinical Oncology, Ospedale Santa Chiara, Trento, Italy.
²⁷ Department for Respiratory Medicine and Thoracic Oncology, Klinikum Rheine - Mathias-Spital, Rheine, Germany.
²⁸ Oncology Clinic, Policlinico SS. Annunziata, Chieti, Italy.
²⁹ Asklepios Cancer Center Hamburg, Asklepios Klinikum Harburg, Hamburg, Harburg, Germany.
³⁰ University of Torino, Department of Oncology at San Luigi Hospital, Orbassano (Torino), Italy.
³¹ Department of Surgery, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.

PMID: 35086737
DOI: 10.1016/j.annonc.2022.01.005

Published Erratum

Corrigendum to "International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer": [Annals of Oncology 33 (2022) 57-66]

S Novello et al. Ann Oncol. 2022 Apr.

. 2022 Apr;33(4):454.

doi: 10.1016/j.annonc.2022.01.005. Epub 2022 Jan 25.

Authors

Affiliations

¹ University of Torino, Department of Oncology at San Luigi Hospital, Orbassano (Torino), Italy. Electronic address: silvia.novello@unito.it.
² Laboratory of Methodology for Clinical Research, Oncology Department at Instituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
³ Department of Respiratory Diseases, Evangelische Lungenklinik Berlin, Berlin, Germany.
⁴ Evangelische Lungenklinik Berlin, Berlin, Germany.
⁵ Thorax Center Clinic for Haematology, Oncology, Pulmonology and Palliative Medicine, Evangelisches Krankenhaus Hamm, Hamm, Germany.
⁶ Department of Pneumology, Maria Hilf Hospital, Moenchengladbach, Germany.
⁷ Esslingen Cancer Center Department of Oncology, Gastroenterology and Infectious Diseases Klinikum Esslingen, Esslingen, Germany.
⁸ Division of Oncology, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy.
⁹ Lung Clinic, Cologne-Merheim Hospital, Cologne, Germany.
¹⁰ Division of Clinical Oncology A, Istituto Nazionale Regina Elena per lo Studio e la Cura dei Tumori, Rome, Italy.
¹¹ Department of Pulmonology, Internal Medicine II, University of Ulm, Ulm, Germany.
¹² Division of Clinical Oncology, Ospedale di Sondalo, Sondrio, Italy.
¹³ Division of Clinical Oncology, AOU Maggiore della Carità, Novara, Italy.
¹⁴ Division of Clinical Oncology I, AOU Città della Salute e della Scienza, Turin, Italy.
¹⁵ Division of Clinical Oncology and Thoracic Pneumology, IRCCS Fondazione Pascale, Naples, Italy.
¹⁶ Complex Operative Unit of Oncology - Gruppo Interdisciplinare Veronese Oncologia Polmonare (GIVOP), Verona, Italy.
¹⁷ Division of Clinical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
¹⁸ Division of Clinical Oncology, Azienda Ospedaliera di Perugia, Ospedale Santa Maria della Misericordia, Perugia, Italy.
¹⁹ Oncology Department, LungenClinic Grosshansdorf, Grosshansdorf, Germany.
²⁰ Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
²¹ University Hospital Carl Gustav Carus Medical Department I Dresden, Dresden, Germany.
²² Clinic for Haematology and Oncoloy, Medizinischer Campus Universität Oldenburg, Oldenburg, Germany.
²³ Department of Oncology, Presidio Ospedaliero Universitario Santa Maria della Misericordia, Azienda Sanitaria Universitaria Integrata Friuli Centrale, Udine, Italy.
²⁴ Medical Oncology, Fondazione IRCCS Policlinico S. Matteo and Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy.
²⁵ Division of Clinical Oncology, Centro di Riferimento Oncologico, Aviano, Italy.
²⁶ Division of Clinical Oncology, Ospedale Santa Chiara, Trento, Italy.
²⁷ Department for Respiratory Medicine and Thoracic Oncology, Klinikum Rheine - Mathias-Spital, Rheine, Germany.
²⁸ Oncology Clinic, Policlinico SS. Annunziata, Chieti, Italy.
²⁹ Asklepios Cancer Center Hamburg, Asklepios Klinikum Harburg, Hamburg, Harburg, Germany.
³⁰ University of Torino, Department of Oncology at San Luigi Hospital, Orbassano (Torino), Italy.
³¹ Department of Surgery, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.

PMID: 35086737
DOI: 10.1016/j.annonc.2022.01.005

No abstract available

PubMed Disclaimer

Erratum for

International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer.
Novello S, Torri V, Grohe C, Kurz S, Serke M, Wehler T, Meyer A, Ladage D, Geissler M, Colantonio I, Cauchi C, Stoelben E, Ceribelli A, Kropf-Sanchen C, Valmadre G, Borra G, Schena M, Morabito A, Santo A, Gregorc V, Chiari R, Reck M, Schmid-Bindert G, Folprecht G, Griesinger F, Follador A, Pedrazzoli P, Bearz A, Caffo O, Dickgreber NJ, Irtelli L, Wiest G, Monica V, Porcu L, Manegold C, Scagliotti GV. Novello S, et al. Ann Oncol. 2022 Jan;33(1):57-66. doi: 10.1016/j.annonc.2021.09.017. Epub 2021 Oct 5. Ann Oncol. 2022. PMID: 34624497 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Affiliations

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources